Literature DB >> 29954903

Complete Draft Genome Sequence of an Extended-Spectrum β-Lactamase-Producing Citrobacter freundii Strain Recovered from the Intestine of a House Sparrow (Passer domesticus) in Germany, 2017.

Valerie Osieka1, Mirjam Grobbel1, Silvia Schmoger1, Claudia A Szentiks2, Alexandra Irrgang1, Annemarie Käsbohrer1,3, Bernd-Alois Tenhagen1, Jens A Hammerl4.   

Abstract

Here, we announce the genome of an extended-spectrum β-lactamase-producing Citrobacter freundii strain isolated from the cecum of a house sparrow that was found dead in Berlin-Lichtenberg, Germany, in 2017. This isolate exhibits increased MICs for several antimicrobials and a comprehensive set of acquired resistance determinants potentially involved in horizontal gene transfer.
Copyright © 2018 Osieka et al.

Entities:  

Year:  2018        PMID: 29954903      PMCID: PMC6025936          DOI: 10.1128/genomeA.00599-18

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Citrobacter freundii is a Gram-negative, opportunistic pathogen of the family Enterobacteriaceae. It is widely distributed in the environment and is also present in the intestine of wildlife, livestock, and humans. In the past, the pathogenic potential of this bacterium was considered low, but C. freundii is now recognized as an important nosocomial pathogen causing both superficial wound infections and life-threatening infections (1, 2), especially in neonates and elderly and immunocompromised persons (3). C. freundii has been shown to adapt efficiently to prevailing environmental conditions by acquiring genetic material from other bacteria. The uptake of various antimicrobial resistance determinants and the spread of multidrug-resistant (MDR) C. freundii clones, especially in health care units, are major public health issues (4). Further information on the biology and genetics will be needed to understand the evolution and dissemination of MDR C. freundii strains. Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae were recovered from fecal and cecal samples of German wildlife by cultivation on MacConkey agar supplemented with 1 mg/liter cefotaxime (5). Representative colonies of each sample were identified by a MALDI Biotyper (Bruker, Bremen, Germany). The isolates were tested for their susceptibility to antimicrobial substances using the broth microdilution method according to CLSI guideline M07 (CLSI M07-A10) (6) and assessed according to EUCAST ECOFFs (http://www.eucast.org). Among all isolated C. freundii, strain 236-17-2 attracted attention because of a comprehensive antimicrobial resistance pattern, with high MIC(s) for ampicillin (>64 mg/liter), chloramphenicol (>128 mg/liter), ciprofloxacin (0.5 mg/liter), nalidixic acid (>128 mg/liter), sulfamethoxazole (>1024 mg/liter), tetracycline (64 mg/liter), trimethoprim (>32 mg/liter), cefepime (0.5 mg/liter), ertapenem (0.12 mg/liter), cefotaxime (32 mg/liter), cefoxitin (>64 mg/liter), and ceftazidime (32 mg/liter). Here, we announce the draft genome of this isolate, which was recovered from the intestine of a house sparrow (Passer domesticus) in Berlin-Lichtenberg (Germany) in 2017. Genome sequencing was performed using DNA extracted with the PureLink Genomic DNA minikit (Invitrogen, Carlsbad, CA, USA). Short-read sequencing (MiSeq Reagent v3 600-cycle kit, Illumina, San Diego, USA) was conducted on a MiSeq benchtop sequencer using sequencing libraries prepared with the Nextera XT DNA sample preparation kit as previously described (6). De novo genome assembly was performed using the PATRIC database (https://www.patricbrc.org/) and resulted in 36 contigs with an average sequence coverage of 15 per consensus base. The resulting genome consists of 4,973,288 bp with an average G+C content of 51.51%. For initial genome annotation, the automated Prokaryotic Genome Annotation Pipeline of the NCBI database (7) was used, resulting in the identification of 4,856 genes, 4,753 coding sequences, 103 RNAs (16 rRNAs, 75 tRNAs, and 12 noncoding RNAs [ncRNAs]), and 130 pseudogenes. The antimicrobial resistance pattern of isolate 236-17-2 was partially confirmed by in silico detection of the acquired resistance genes for aminoglycosides (strA and strB), beta-lactams (blaCMY-67 and blaTEM-1A), phenicols (catA1), sulfonamides (sul1), tetracyclines [tet(A)], and trimethoprim (dfrA1) using ResFinder3.0 (https://cge.cbs.dtu.dk/services/ResFinder/). Further analyses will be necessary to determine the locations of the resistance determinants on potential mobile elements (i.e., transposons and plasmids) and their role in the transmission to other bacteria of the Enterobacteriaceae.

Accession number(s).

The complete genome sequence of the C. freundii strain 236-17-2 genome was deposited in GenBank under accession number PQFB00000000.
  6 in total

1.  Clinical and molecular epidemiology of multidrug-resistant Citrobacter spp. infections in a French university hospital.

Authors:  J-P Lavigne; C Defez; N Bouziges; A Mahamat; A Sotto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-06       Impact factor: 3.267

2.  Characterization of illegal food items and identification of foodborne pathogens brought into the European Union via two major German airports.

Authors:  Janine Beutlich; Jens Andre Hammerl; Bernd Appel; Karsten Nöckler; Reiner Helmuth; Kristine Jöst; Marie-Luise Ludwig; Christine Hanke; Dirk Bechtold; Anne Mayer-Scholl
Journal:  Int J Food Microbiol       Date:  2014-10-24       Impact factor: 5.277

3.  Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004.

Authors:  Shawn R Lockhart; Murray A Abramson; Susan E Beekmann; Gale Gallagher; Stefan Riedel; Daniel J Diekema; John P Quinn; Gary V Doern
Journal:  J Clin Microbiol       Date:  2007-08-22       Impact factor: 5.948

4.  Citrobacter infections in a general hospital: characteristics and outcomes.

Authors:  G Samonis; D E Karageorgopoulos; D P Kofteridis; D K Matthaiou; V Sidiropoulou; S Maraki; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-08-06       Impact factor: 3.267

5.  Clinical features and antimicrobial susceptibility trends in Citrobacter freundii bacteremia.

Authors:  Ying-Sheng Chen; Wing-Wai Wong; Chang-Phone Fung; Kwok-Woon Yu; Cheng-Yi Liu
Journal:  J Microbiol Immunol Infect       Date:  2002-06       Impact factor: 4.399

6.  Complete Genome Sequence of a blaCTX-M-1-Harboring Escherichia coli Isolate Recovered from Cattle in Germany.

Authors:  Jens A Hammerl; Alexandra Irrgang; Mirjam Grobbel; Bernd-Alois Tenhagen; Annemarie Käsbohrer
Journal:  Genome Announc       Date:  2018-01-25
  6 in total
  3 in total

1.  Genetic characterization of a novel sequence type of multidrug-resistant Citrobacter freundii strain recovered from wastewater treatment plant.

Authors:  Xiawei Jiang; Xinjie Cui; Wenhong Liu; Hao Xu; Beiwen Zheng
Journal:  Infect Drug Resist       Date:  2019-09-06       Impact factor: 4.003

2.  Co-Production of NDM-1 and OXA-10 β-Lactamase in Citrobacter braakii Strain Causing Urinary Tract Infection.

Authors:  Huiming Han; Zhi Zhao; Yan Lin; Baihui Lin; Hao Xu; Beiwen Zheng
Journal:  Infect Drug Resist       Date:  2022-03-19       Impact factor: 4.003

3.  Birds Kept in the German Zoo "Tierpark Berlin" Are a Common Source for Polyvalent Yersinia pseudotuberculosis Phages.

Authors:  Jens Andre Hammerl; Andrea Barac; Anja Bienert; Aslihan Demir; Niklas Drüke; Claudia Jäckel; Nina Matthies; Jin Woo Jun; Mikael Skurnik; Juliane Ulrich; Stefan Hertwig
Journal:  Front Microbiol       Date:  2022-01-03       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.